Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression

被引:10
|
作者
Tomizawa, Minoru [1 ]
Shinozaki, Fuminobu [2 ]
Motoyoshi, Yasufumi [3 ]
Sugiyama, Takao [4 ]
Yamamoto, Shigenori [5 ]
Ishige, Naoki [6 ]
机构
[1] Natl Hosp Org, Shimoshizu Hosp, Dept Gastroenterol, Chiba 2840003, Japan
[2] Natl Hosp Org, Shimoshizu Hosp, Dept Radiol, Chiba 2840003, Japan
[3] Natl Hosp Org, Shimoshizu Hosp, Dept Neurol, Chiba 2840003, Japan
[4] Natl Hosp Org, Shimoshizu Hosp, Dept Rheumatol, Chiba 2840003, Japan
[5] Natl Hosp Org, Shimoshizu Hosp, Dept Pediat, Chiba 2840003, Japan
[6] Natl Hosp Org, Shimoshizu Hosp, Dept Neurosurg, Chiba 2840003, Japan
关键词
scratch assay; quantitative polymerase chain reaction; MTS assay; CYCLIN D1; CANCER; INVASION;
D O I
10.3892/ol.2015.3789
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis negatively affects the prognosis of hepatocellular carcinoma (HCC). In the present study, niclosamide, which is known to suppress the proliferation of HCC cells, was investigated for possible suppressant effects on the migration of HCC cells. HLF and PLC/PRF/5 HCC cells were cultured in the presence of niclosamide. Cell proliferation was analyzed using the MTS assay. Cell migration was measured by performing a scratch assay. Expression levels of cyclin D1 and matrix metalloproteinase 9 (MMP9) were analyzed by performing revers transcription-quantitative polymerase chain reaction. Compared with the control treatment, treatment with 10 mu m niclosamide suppressed the proliferation of the HLF and PRL/PRF/5 cells to 49.9 +/- 3.7 and 17.9 +/- 11.5% (P<0.05), respectively. Furthermore, compared with the control treatment, treatment with 1.0 mu M niclosamide downregulated the expression of cyclin D1 to 52.4 +/- 4.4 and 23.9 +/- 5.4% (P<0.05) in the HLF and PRL/PRF/5 cells, respectively. In the scratch assay, treatment of the HLF cells with niclosamide (1.0 mu m) decreased the distance of the scratched line from the growing edge to 4.6 +/- 1.0 mm compared with the 9.2 +/- 1.4 mm observed with the control treatment (P<0.05). Similarly, treatment of the PRL/PRF/5 cells with niclosamide (1.0 mu m) also decreased the distance of the scratched line from the growing edge to 3.0 +/- 0.8 mm compared with the 5.5 +/- 0.9 mm observed with the control treatment (P<0.05). Further, MMP9 expression levels in the HLF cells treated with 1.0 mu m niclosamide decreased to 22.4 +/- 1.76% (P<0.05) compared with those in the untreated control HLF cells. Similarly, expression level of MMP9 in the PRL/PRF/5 cells treated with 1.0 mu m niclosamide deceased to 18.7 +/- 10.7% (P<0.05) compared with those in the untreated control PRL/PRF/5 cells. Overall, niclosamide downregulated the expression of MMP9 in and suppressed the migration of HCC cells.
引用
收藏
页码:3515 / 3518
页数:4
相关论文
共 50 条
  • [21] Capsaicin suppresses the migration and invasion of cholangiocarcinoma cell by downregulation of matrix metalloproteinase-9 expression via AMPK activation.
    Lee, G-R
    Yoon, D-J
    Park, N-H
    Han, I-S
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [22] Mycoplasma pneumoniae downregulates RECK to promote matrix metalloproteinase-9 secretion by bronchial epithelial cells
    Qin, Lianmei
    Liu, Lu
    Wu, Yueping
    Chen, Yiwen
    Wu, Yueyue
    Luo, Haodang
    Xi, Yixuan
    Xiu, Feichen
    Hu, Jun
    Chen, Liesong
    Wu, Ning
    He, Jun
    Zeng, Yanhua
    Zhu, Cuiming
    You, Xiaoxing
    VIRULENCE, 2022, 13 (01) : 1270 - 1284
  • [23] Expression of Matrix Metalloproteinase-9 in Gastric Cancer
    Prathipaa, R.
    Priyathersini, N.
    Thanka, J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [24] Matrix metalloproteinase-9 expression in desmoplastic melanoma
    Hoashi, Toshihiko
    Kikuchi, Kanako
    Watanabe, Shinichi
    Nanko, Hiroko
    Tamaki, Kunihiko
    JOURNAL OF DERMATOLOGY, 2008, 35 (02): : 122 - 123
  • [25] Expression of matrix metalloproteinase-9 in ischemic myocardium
    Pangonyte, D.
    Buneviciene, V.
    Utkiene, L.
    Peciulyte, L.
    Kupryte, M.
    VIRCHOWS ARCHIV, 2016, 469 : S244 - S244
  • [26] Expression of matrix metalloproteinase-9 in adenocarcinoma of prostate
    Andruchin, M. I.
    Pulbere, S. A.
    Loktev, A. V.
    Babichenko, I. I.
    ONKOUROLOGIYA, 2014, 10 (02): : 35 - 37
  • [27] Effect of erythromycin on matrix metalloproteinase-9 and cell migration
    Hashimoto, N
    Kawabe, T
    Hara, T
    Imaizumi, K
    Wakayama, H
    Saito, H
    Shimokata, K
    Hasegawa, Y
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 137 (03): : 176 - 183
  • [28] Hemodynamic environment regulates expression of matrix metalloproteinase-9 in endothelial cells
    Magid, R
    Murphy, TJ
    Galis, ZS
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 690 - 690
  • [29] Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion
    Lin, LI
    Ke, YF
    Ko, YC
    Lin, JK
    ONCOLOGY, 1998, 55 (04) : 349 - 353
  • [30] Sorafenib Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells Through Suppression of Matrix Metalloproteinase Expression
    Ha, Tae-Yong
    Hwang, Shin
    Moon, Ki-Myeong
    Won, You-Jin
    Song, Gi-Won
    Kim, Nayoung
    Tak, EunYoung
    Ryoo, Baek-Yeol
    Hong, Hea-Nam
    ANTICANCER RESEARCH, 2015, 35 (04) : 1967 - 1976